This event is sure to be a great gathering for clinical research professionals. Gretchen Bowker, Pearl IRB COO is speaking on Monday, May 23rd at 10:30 am. Session title: Recent Developments in Human Subjects Protection Regulation and, where are we going? We will...
We are thrilled to have Rachel Ochs-Ross, M.D., J.D. join our Board as co-chair. She is an experienced Neurologist who has extensive experience guiding all phases of clinical drug development, from early compound assessment through Phase IV clinical studies and has...
Our President and CEO, Diana Caldwell will be attending the 2011 Diversity Alliance for Science Conference May 16-18, 2011. Let us know if you’ll be at the conference or in the area. To learn more, click here. We are proud to be members of this great...
The lithium in ALS patients study publised by Wicks, Vaughan, Massagli and Heywood released online in nature biotechnology on April 24, sparked a Wall Street Article Health Industry article entitled “ALS Study Shows Social Media’s Value as Research...
